Inventor

JIA ZHOU

Inventor
US

Overview

24→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07DHeterocyclic compounds12%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
Y02ATechnologies for adaptation to climate change6%
C12NMicroorganisms or enzymes5%
A61BDiagnosis3%
A61NElectrotherapy3%
B01LChemical or physical laboratory apparatus for general use3%
C07HSugars3%
PatentTitleYear
12,590,954Neural stem cell-induced differential medium and induction differentiation method202612,545,892Application of TGF-B inhibitor in inducing neural stem cells and organoid formation202612,504,613Apparatus and system for particle manipulation202512,472,385High-intensity focused ultrasonic device and control method202512,441,686Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists202512,303,900Photoacoustic tweezers202512,291,553Non-opioid anti-pain medication2025RE050319Compounds and methods for treating cancer202512,220,603High-intensity focused ultrasound apparatus and control method202512,077,540Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues202412,043,602Fendiline derivatives2024D1035123Electronic atomizer202412,025,459Methods and apparatuses for navigation guidance and establishing a three-dimensional real scene model, device and medium202411,911,940In-mold spraying system and process method202411,773,065Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists202311,767,303Compounds and methods for inhibiting viral replication and methods of treating and preventing flaviviral infections202311,697,813Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis202311,618,845Polymer dispersions for wax inhibition during stimulation treatment202311,407,752Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues202211,389,433BRD4 inhibitor treatment of IgE-mediated diseases202211,341,306Method for building spice circuit model of an optical coupler2022D0946230Cart2022D0943561TV cart202211,224,608Compounds and methods for treating cancer2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to UNIV TEXAS (8)· patent assignee history
2022–2025Patents assigned to DANA FARBER CANCER INST INC (2)· patent assignee history
2022Patents assigned to IWORKHUB LTD (2)· patent assignee history
2022–2025Based in US· patent location history
2022–2026Based in CN· patent location history
2022Based in SG· patent location history
2025Patents assigned to ULTRASOUND ASSISTED MEDTECH PTE LTD (2)· patent assignee history
2026Patents assigned to IREGENE THERAPEUTICS CO LTD (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV TEXAS82022–2025
DANA FARBER CANCER INST INC22022–2025
IREGENE THERAPEUTICS CO LTD22026
IWORKHUB LTD22022
ULTRASOUND ASSISTED MEDTECH PTE LTD22025
Locations
LocationPatentsSpan
US122022–2025
CN112022–2026
SG12022